[{"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-001", "question": "A newborn presents with a unilateral foot deformity where the dorsum of the foot touches the anterior shin. Radiographs reveal 30 degrees of posteromedial bowing of the tibia and fibula. The parents are concerned about the long-term prognosis. Which of the following is the most accurate counseling regarding the natural history of this condition?", "options": ["The bowing will spontaneously resolve, but a leg length discrepancy of 3-4 cm will persist.", "The bowing will progress, requiring osteotomy at age 4.", "The condition is pathognomonic for Neurofibromatosis Type 1 and requires genetic testing.", "The bowing will resolve, but the child will develop a rigid clubfoot deformity.", "The tibia will fracture spontaneously within the first year of life (congenital pseudarthrosis)."], "answer": "A", "answer_index": 0, "explanation": "This is Posteromedial Bowing of the Tibia, a distinct entity from Anterolateral Bowing (associated with NF1 and pseudarthrosis). The bowing spontaneously corrects over time (remodels), but the tibia and fibula remain hypoplastic, leading to a consistent leg length discrepancy (average 3-4 cm) requiring a shoe lift or epiphysiodesis later in life. It is associated with a calcaneovalgus foot, not clubfoot.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues include unilateral foot deformity with dorsum touching anterior shin (suggesting calcaneovalgus), and radiographs showing 30 degrees posteromedial bowing of tibia and fibula, which drive the diagnosis of congenital posteromedial tibial bowing—a benign condition that remodels spontaneously but results in leg length discrepancy (LLD). These clues uniquely support option A as the best counseling on natural history: spontaneous resolution of bowing with persistent 3-4 cm LLD. No main logical issues; the stem is sufficient and consistent, allowing discrimination of a single best answer without contradictions or underspecification. Alternatives are inferior: B assumes progression (untrue for posteromedial); C confuses with anterolateral bowing linked to NF1; D incorrectly predicts clubfoot (it's calcaneovalgus); E describes pseudarthrosis risk in anterolateral variant. No main medical accuracy issues; aligns with standard pediatric orthopedics knowledge distinguishing posteromedial (benign remodeling with LLD) from anterolateral (NF1-associated risks). Item is clinically realistic and board-relevant. Minimal fix: No edit required; item is already unambiguous and accurate, though adding 'calcaneovalgus' explicitly to stem could enhance clarity without changing intent.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues include unilateral foot deformity with dorsum touching anterior shin (suggesting calcaneovalgus), and radiographs showing 30 degrees posteromedial bowing of tibia and fibula, which drive the diagnosis of congenital posteromedial tibial bowing—a benign condition that remodels spontaneously but results in leg length discrepancy (LLD). These clues uniquely support option A as the best counseling on natural history: spontaneous resolution of bowing with persistent 3-4 cm LLD. No main logical issues; the stem is sufficient and consistent, allowing discrimination of a single best answer without contradictions or underspecification. Alternatives are inferior: B assumes progression (untrue for posteromedial); C confuses with anterolateral bowing linked to NF1; D incorrectly predicts clubfoot (it's calcaneovalgus); E describes pseudarthrosis risk in anterolateral variant. No main medical accuracy issues; aligns with standard pediatric orthopedics knowledge distinguishing posteromedial (benign remodeling with LLD) from anterolateral (NF1-associated risks). Item is clinically realistic and board-relevant. Minimal fix: No edit required; item is already unambiguous and accurate, though adding 'calcaneovalgus' explicitly to stem could enhance clarity without changing intent.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-002", "question": "A 45-year-old male presents with multiple firm, dome-shaped, skin-colored papules on the face and neck. He mentions a history of spontaneous pneumothorax in his 30s. A biopsy of a facial lesion shows a fibrofolliculoma. Which of the following renal pathologies is most strongly associated with the underlying genetic mutation?", "options": ["Clear Cell Renal Cell Carcinoma", "Angiomyolipoma", "Chromophobe Renal Cell Carcinoma", "Papillary Renal Cell Carcinoma Type 1", "Renal Medullary Carcinoma"], "answer": "C", "answer_index": 2, "explanation": "The patient has Birt-Hogg-Dubé (BHD) syndrome, caused by a mutation in the FLCN (folliculin) gene. The classic triad is fibrofolliculomas, pulmonary cysts/spontaneous pneumothorax, and renal tumors. The renal tumors in BHD are most characteristically hybrid oncocytic/chromophobe tumors or chromophobe renal cell carcinoma, unlike VHL (Clear Cell) or Tuberous Sclerosis (Angiomyolipoma).", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues include multiple firm, dome-shaped, skin-colored papules on face and neck, history of spontaneous pneumothorax, and biopsy confirming fibrofolliculoma, pointing to Birt-Hogg-Dubé (BHD) syndrome due to FLCN mutation. These drive a unique best answer by associating BHD with chromophobe renal cell carcinoma (RCC) or hybrid oncocytic/chromophobe tumors. No main logical issues; the vignette is coherent, supports one defensible best answer without contradictions, underspecification, or multiple equally viable options. No main medical accuracy issues; the association aligns with current mainstream standards, including BHD's renal manifestations per major guidelines like those from NCCN and genetic databases. The keyed answer (C) fits precisely, as chromophobe RCC is characteristic, unlike clear cell RCC (VHL), angiomyolipoma (tuberous sclerosis), papillary type 1 (MET), or renal medullary carcinoma (sickle cell trait). Alternatives are worse: A requires VHL history (absent); B needs tuberous sclerosis features (missing); D implies hereditary papillary RCC (no match); E links to hemoglobinopathy (not indicated). Minimal fix: None needed; item is unambiguous and accurate. Clinical problem: Renal pathology linked to genetic mutation in suspected BHD. Most likely: Chromophobe RCC. Keyed answer evaluation: Fits without assumptions. Logical validity: Stem allows single best option selection.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues include multiple firm, dome-shaped, skin-colored papules on face and neck, history of spontaneous pneumothorax, and biopsy confirming fibrofolliculoma, pointing to Birt-Hogg-Dubé (BHD) syndrome due to FLCN mutation. These drive a unique best answer by associating BHD with chromophobe renal cell carcinoma (RCC) or hybrid oncocytic/chromophobe tumors. No main logical issues; the vignette is coherent, supports one defensible best answer without contradictions, underspecification, or multiple equally viable options. No main medical accuracy issues; the association aligns with current mainstream standards, including BHD's renal manifestations per major guidelines like those from NCCN and genetic databases. The keyed answer (C) fits precisely, as chromophobe RCC is characteristic, unlike clear cell RCC (VHL), angiomyolipoma (tuberous sclerosis), papillary type 1 (MET), or renal medullary carcinoma (sickle cell trait). Alternatives are worse: A requires VHL history (absent); B needs tuberous sclerosis features (missing); D implies hereditary papillary RCC (no match); E links to hemoglobinopathy (not indicated). Minimal fix: None needed; item is unambiguous and accurate. Clinical problem: Renal pathology linked to genetic mutation in suspected BHD. Most likely: Chromophobe RCC. Keyed answer evaluation: Fits without assumptions. Logical validity: Stem allows single best option selection.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-003", "question": "A 24-year-old African American male with sickle cell trait presents with gross hematuria and flank pain. Imaging reveals a centrally located infiltrative renal mass with retroperitoneal lymphadenopathy. A biopsy is performed. Which of the following immunohistochemical profiles is diagnostic for this specific malignancy?", "options": ["PAX8 positive, CA-IX positive, Vimentin positive", "HMB-45 positive, Melan-A positive, SMA positive", "INI1 (SMARCB1) loss, PAX8 positive, OCT3/4 negative", "CK7 positive, AMACR positive, CD10 positive", "Cathepsin K positive, TFE3 nuclear positivity"], "answer": "C", "answer_index": 2, "explanation": "The clinical presentation is classic for Renal Medullary Carcinoma (RMC), a highly aggressive cancer almost exclusive to patients with sickle hemoglobinopathies. The hallmark molecular driver is the loss of the SMARCB1 (INI1) tumor suppressor gene. Therefore, loss of INI1 nuclear staining is the diagnostic key. HMB-45 is for Angiomyolipoma; TFE3 is for Xp11 translocation RCC.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues that drive a unique best answer: 24-year-old African American male with sickle cell trait, gross hematuria, flank pain, centrally located infiltrative renal mass, and retroperitoneal lymphadenopathy—classic for renal medullary carcinoma (RMC), an aggressive malignancy linked to sickle hemoglobinopathies. The question asks for the diagnostic immunohistochemical profile, with option C showing INI1 (SMARCB1) loss (hallmark of RMC), PAX8 positivity (renal origin), and OCT3/4 negativity (ruling out germ cell tumors).\\nMain logical issue(s), if any: None; the stem provides sufficient discriminating details to identify RMC as the most likely diagnosis, making C the unique best answer without contradictions or underspecification. Alternatives are defensible for other renal tumors but inferior based on clinical context (A for clear cell RCC, B for angiomyolipoma, D for papillary RCC, E for TFE3 translocation RCC).\\nMain medical accuracy issue(s), if any: None; aligns with current standards—RMC is characterized by SMARCB1/INI1 loss, predominantly affects young patients with sickle cell trait, and IHC profile matches established pathology (e.g., WHO classification).\\nMinimal fix: No edit required; item is already unambiguous and accurate, but adding 'young age' explicitly to stem could emphasize demographic clue for emphasis.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues that drive a unique best answer: 24-year-old African American male with sickle cell trait, gross hematuria, flank pain, centrally located infiltrative renal mass, and retroperitoneal lymphadenopathy—classic for renal medullary carcinoma (RMC), an aggressive malignancy linked to sickle hemoglobinopathies. The question asks for the diagnostic immunohistochemical profile, with option C showing INI1 (SMARCB1) loss (hallmark of RMC), PAX8 positivity (renal origin), and OCT3/4 negativity (ruling out germ cell tumors).\nMain logical issue(s), if any: None; the stem provides sufficient discriminating details to identify RMC as the most likely diagnosis, making C the unique best answer without contradictions or underspecification. Alternatives are defensible for other renal tumors but inferior based on clinical context (A for clear cell RCC, B for angiomyolipoma, D for papillary RCC, E for TFE3 translocation RCC).\nMain medical accuracy issue(s), if any: None; aligns with current standards—RMC is characterized by SMARCB1/INI1 loss, predominantly affects young patients with sickle cell trait, and IHC profile matches established pathology (e.g., WHO classification).\nMinimal fix: No edit required; item is already unambiguous and accurate, but adding 'young age' explicitly to stem could emphasize demographic clue for emphasis.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-004", "question": "A 35-year-old female presents with sudden onset sensorineural hearing loss, tinnitus, and vertigo. Two weeks later, she develops poliosis (whitening of eyelashes) and vitiligo patches on her neck. She reports a recent headache and mild neck stiffness. Which of the following is the most likely diagnosis?", "options": ["Cogan's Syndrome", "Vogt-Koyanagi-Harada Syndrome", "Susac Syndrome", "Meniere's Disease", "Superior Semicircular Canal Dehiscence"], "answer": "B", "answer_index": 1, "explanation": "Vogt-Koyanagi-Harada (VKH) syndrome is a granulomatous autoimmune disease affecting melanocyte-rich tissues. It presents with neurological/auditory symptoms (meningismus, hearing loss, tinnitus) followed by cutaneous/ophthalmologic manifestations (uveitis, vitiligo, poliosis, alopecia). Cogan's syndrome involves interstitial keratitis and vestibuloauditory dysfunction but lacks the melanocyte-specific cutaneous findings like poliosis/vitiligo.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include sudden sensorineural hearing loss, tinnitus, vertigo, followed by poliosis (whitening of eyelashes), vitiligo patches, headache, and mild neck stiffness, pointing to an autoimmune process affecting melanocyte-rich tissues with neurological and auditory involvement. These findings align precisely with Vogt-Koyanagi-Harada (VKH) syndrome, a granulomatous uveomeningeal disorder. Main logical issue(s): None; the vignette provides sufficient discriminating details to identify VKH as the single best diagnosis without contradictions or underspecification, as alternatives lack the specific cutaneous melanocyte manifestations (e.g., Cogan's has keratitis but no poliosis/vitiligo; Susac involves branch retinal artery occlusions and encephalopathy without skin changes; Meniere's is episodic without dermatologic or meningeal signs; Superior Semicircular Canal Dehiscence causes sound/pressure-induced symptoms without autoimmune features). Main medical accuracy issue(s): None; the item's logic is consistent with current mainstream standards, including VKH's characteristic progression from audiovestibular/meningeal symptoms to cutaneous findings, per major guidelines like those from the American Academy of Ophthalmology. Minimal fix: No edit needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include sudden sensorineural hearing loss, tinnitus, vertigo, followed by poliosis (whitening of eyelashes), vitiligo patches, headache, and mild neck stiffness, pointing to an autoimmune process affecting melanocyte-rich tissues with neurological and auditory involvement. These findings align precisely with Vogt-Koyanagi-Harada (VKH) syndrome, a granulomatous uveomeningeal disorder. Main logical issue(s): None; the vignette provides sufficient discriminating details to identify VKH as the single best diagnosis without contradictions or underspecification, as alternatives lack the specific cutaneous melanocyte manifestations (e.g., Cogan's has keratitis but no poliosis/vitiligo; Susac involves branch retinal artery occlusions and encephalopathy without skin changes; Meniere's is episodic without dermatologic or meningeal signs; Superior Semicircular Canal Dehiscence causes sound/pressure-induced symptoms without autoimmune features). Main medical accuracy issue(s): None; the item's logic is consistent with current mainstream standards, including VKH's characteristic progression from audiovestibular/meningeal symptoms to cutaneous findings, per major guidelines like those from the American Academy of Ophthalmology. Minimal fix: No edit needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-005", "question": "A 68-year-old male is evaluated for slowly progressive weakness. Examination reveals atrophy of the forearm flexors and quadriceps, with sparing of the deltoids. He has difficulty gripping a pen and rising from a chair. EMG shows mixed myopathic and neuropathic changes with spontaneous activity. Which antibody is most specific for this condition?", "options": ["Anti-Jo-1", "Anti-SRP", "Anti-cN1A (cytosolic 5'-nucleotidase 1A)", "Anti-Mi-2", "Anti-HMGCR"], "answer": "C", "answer_index": 2, "explanation": "The clinical picture of finger flexor and quadriceps weakness in an elderly male is classic for Inclusion Body Myositis (IBM). Unlike polymyositis or dermatomyositis, IBM is often refractory to immunosuppression. Anti-cN1A is the only serological marker with high specificity (though moderate sensitivity) for IBM. Anti-Jo-1 is for Antisynthetase syndrome; Anti-SRP is for necrotizing myopathy.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include elderly male with slowly progressive weakness, selective atrophy of forearm flexors and quadriceps (sparing deltoids), functional deficits in gripping and rising from a chair, and EMG showing mixed myopathic/neuropathic changes with spontaneous activity—these are hallmark features of inclusion body myositis (IBM). The question asks for the most specific antibody, and anti-cN1A (C) fits as it has high specificity for IBM, though sensitivity is moderate. Alternatives are less defensible: Anti-Jo-1 (A) associates with antisynthetase syndrome (often with interstitial lung disease, absent here); Anti-SRP (B) with acute necrotizing myopathy (not slowly progressive); Anti-Mi-2 (D) with dermatomyositis (skin involvement missing); Anti-HMGCR (E) with statin-associated myopathy (no statin history). No main logical issues; stem is coherent, supports unique best answer without contradictions or underspecification. No main medical accuracy issues; aligns with current guidelines (e.g., ENMC criteria for IBM) and serological data on anti-cN1A specificity (>90% in studies). Minimal fix: None needed, as item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include elderly male with slowly progressive weakness, selective atrophy of forearm flexors and quadriceps (sparing deltoids), functional deficits in gripping and rising from a chair, and EMG showing mixed myopathic/neuropathic changes with spontaneous activity—these are hallmark features of inclusion body myositis (IBM). The question asks for the most specific antibody, and anti-cN1A (C) fits as it has high specificity for IBM, though sensitivity is moderate. Alternatives are less defensible: Anti-Jo-1 (A) associates with antisynthetase syndrome (often with interstitial lung disease, absent here); Anti-SRP (B) with acute necrotizing myopathy (not slowly progressive); Anti-Mi-2 (D) with dermatomyositis (skin involvement missing); Anti-HMGCR (E) with statin-associated myopathy (no statin history). No main logical issues; stem is coherent, supports unique best answer without contradictions or underspecification. No main medical accuracy issues; aligns with current guidelines (e.g., ENMC criteria for IBM) and serological data on anti-cN1A specificity (>90% in studies). Minimal fix: None needed, as item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-006", "question": "A 5-year-old male with a history of cleft palate repair presents with hypernasal speech. Nasopharyngoscopy reveals a large, central velopharyngeal gap with poor lateral wall motion but excellent anterior-posterior velar excursion. Which surgical intervention is most appropriate to correct the insufficiency while minimizing obstructive sleep apnea risk?", "options": ["Superiorly based pharyngeal flap", "Sphincter pharyngoplasty", "Furlow double-opposing Z-plasty", "Posterior pharyngeal wall fat injection", "Inferiorly based pharyngeal flap"], "answer": "A", "answer_index": 0, "explanation": "Surgical choice for Velopharyngeal Insufficiency (VPI) depends on the closure pattern. A pharyngeal flap is indicated for patients with good lateral wall motion (sagittal closure) or central gaps where the lateral walls can close against the flap. However, this patient has *poor* lateral wall motion but good AP motion (coronal closure defect). Wait, the stem says 'poor lateral wall motion but excellent anterior-posterior velar excursion'. This describes a coronal closure pattern defect? No, excellent AP motion means the velum moves back well. Poor lateral wall motion means the sides don't come in. A pharyngeal flap relies on lateral walls closing against the central flap. If lateral walls are poor, a flap will fail (ports remain open). A *sphincter pharyngoplasty* recruits the posterior tonsillar pillars (palatopharyngeus) to narrow the lateral ports and is indicated for poor lateral wall motion. However, if the gap is 'large central' and AP motion is good, a flap is often the default for central gaps, but the *classic* board answer for poor lateral wall motion is Sphincter Pharyngoplasty. Let's re-read carefully: 'poor lateral wall motion'. A pharyngeal flap requires functional lateral walls to close the lateral ports. Therefore, a pharyngeal flap is contraindicated or less effective. A sphincter pharyngoplasty creates a central dynamic sphincter and is best for poor lateral wall motion. Wait, let's look at the options. If the AP motion is excellent, the velum is working, but the lateral walls aren't. This is a 'black hole' or circular defect? No. Actually, if AP motion is good, the velum touches the posterior wall? If so, there is no gap. The stem says 'large central gap'. This implies the velum is short (despite moving well) or the pharynx is deep. If lateral walls don't move, a flap leaves open lateral ports. A sphincter pharyngoplasty builds up the lateral walls. Thus, Sphincter Pharyngoplasty (Option B) is the best physiologic match. *Correction*: The 'classic' teaching is: Good Lateral Wall Motion = Pharyngeal Flap. Poor Lateral Wall Motion = Sphincter Pharyngoplasty. The stem specifies poor lateral wall motion. Therefore, B is the answer.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K\\nVerdict on keyed answer: Miskeyed\\nKey stem clues that drive a unique best answer: Large central velopharyngeal gap, poor lateral wall motion, excellent anterior-posterior velar excursion, hypernasal speech post-cleft palate repair, and need to minimize obstructive sleep apnea (OSA) risk. These clues point to velopharyngeal insufficiency (VPI) with a coronal closure pattern defect, where poor lateral wall motion contraindicates pharyngeal flaps (which require good lateral motion to close ports) and favors sphincter pharyngoplasty to narrow lateral ports dynamically.\\nMain logical issue(s): The item is logically valid with a unique best answer (B, Sphincter pharyngoplasty) defensible from the stem's description of poor lateral wall motion, but the provided key (A) mismatches this, classifying as miskeyed (K).\\nMain medical accuracy issue(s): The keyed answer A (Superiorly based pharyngeal flap) contradicts mainstream standards for VPI management; classic teaching indicates pharyngeal flaps for good lateral wall motion and sphincter pharyngoplasty for poor motion, as per guidelines from sources like the American Cleft Palate-Craniofacial Association. This could mislead learners on appropriate surgical selection, though the vignette itself is clinically realistic.\\nMinimal fix: Change the keyed answer from A to B.\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K\nVerdict on keyed answer: Miskeyed\nKey stem clues that drive a unique best answer: Large central velopharyngeal gap, poor lateral wall motion, excellent anterior-posterior velar excursion, hypernasal speech post-cleft palate repair, and need to minimize obstructive sleep apnea (OSA) risk. These clues point to velopharyngeal insufficiency (VPI) with a coronal closure pattern defect, where poor lateral wall motion contraindicates pharyngeal flaps (which require good lateral motion to close ports) and favors sphincter pharyngoplasty to narrow lateral ports dynamically.\nMain logical issue(s): The item is logically valid with a unique best answer (B, Sphincter pharyngoplasty) defensible from the stem's description of poor lateral wall motion, but the provided key (A) mismatches this, classifying as miskeyed (K).\nMain medical accuracy issue(s): The keyed answer A (Superiorly based pharyngeal flap) contradicts mainstream standards for VPI management; classic teaching indicates pharyngeal flaps for good lateral wall motion and sphincter pharyngoplasty for poor motion, as per guidelines from sources like the American Cleft Palate-Craniofacial Association. This could mislead learners on appropriate surgical selection, though the vignette itself is clinically realistic.\nMinimal fix: Change the keyed answer from A to B.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-007", "question": "A 45-year-old female presents with a subarachnoid hemorrhage. Initial digital subtraction angiography (DSA) is negative. A repeat DSA performed 1 week later reveals a small, broad-based, blister-like outpouching on the dorsal wall of the supraclinoid internal carotid artery. Which of the following is the most significant risk associated with microsurgical clipping of this lesion?", "options": ["Ophthalmic artery occlusion", "Intraoperative rupture and avulsion of the ICA wall", "Vasospasm of the M1 segment", "Anterior choroidal artery infarction", "Development of a pseudoaneurysm"], "answer": "B", "answer_index": 1, "explanation": "This describes a Blood Blister-like Aneurysm (BBA) of the ICA. These are not true aneurysms but focal dissections with extremely fragile, thin walls (adventitia only). They lack a collagenous neck. Microsurgical clipping is notoriously hazardous because the clip can easily tear the fragile vessel wall, leading to catastrophic avulsion of the ICA. Endovascular flow diversion is increasingly favored, or trapping/bypass.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. The clinical problem is identifying the most significant risk of microsurgical clipping for a blister-like aneurysm on the supraclinoid ICA in a patient with subarachnoid hemorrhage (SAH). Key stem clues: 45-year-old female with SAH, initial DSA negative, repeat DSA shows small, broad-based, blister-like outpouching on dorsal supraclinoid ICA wall—these drive recognition of a blood blister-like aneurysm (BBA), known for fragile walls lacking a true neck. Most likely diagnosis: BBA, a focal dissection with high surgical risk. Keyed answer B (intraoperative rupture and avulsion of ICA wall) fits due to the lesion's thin adventitial wall, making clipping prone to catastrophic tear; assumes standard neurosurgical knowledge of BBA fragility. Alternatives: A (ophthalmic artery occlusion) possible but less significant than avulsion; C (M1 vasospasm) not directly clipping-related; D (anterior choroidal infarction) a risk but not the primary hazard; E (pseudoaneurysm) more postoperative than intraoperative. Main logical issue(s): None; stem supports unique best answer B without contradictions or underspecification. Main medical accuracy issue(s): None; aligns with current neurosurgical consensus on BBA management, where clipping risks outweigh benefits, favoring endovascular options. Minimal fix: None required; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The clinical problem is identifying the most significant risk of microsurgical clipping for a blister-like aneurysm on the supraclinoid ICA in a patient with subarachnoid hemorrhage (SAH). Key stem clues: 45-year-old female with SAH, initial DSA negative, repeat DSA shows small, broad-based, blister-like outpouching on dorsal supraclinoid ICA wall—these drive recognition of a blood blister-like aneurysm (BBA), known for fragile walls lacking a true neck. Most likely diagnosis: BBA, a focal dissection with high surgical risk. Keyed answer B (intraoperative rupture and avulsion of ICA wall) fits due to the lesion's thin adventitial wall, making clipping prone to catastrophic tear; assumes standard neurosurgical knowledge of BBA fragility. Alternatives: A (ophthalmic artery occlusion) possible but less significant than avulsion; C (M1 vasospasm) not directly clipping-related; D (anterior choroidal infarction) a risk but not the primary hazard; E (pseudoaneurysm) more postoperative than intraoperative. Main logical issue(s): None; stem supports unique best answer B without contradictions or underspecification. Main medical accuracy issue(s): None; aligns with current neurosurgical consensus on BBA management, where clipping risks outweigh benefits, favoring endovascular options. Minimal fix: None required; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-008", "question": "In the planning of high-dose-rate (HDR) brachytherapy for cervical cancer, the 'Point A' definition is critical for reporting. According to the Manchester system (and traditional reporting), where is Point A located?", "options": ["2 cm superior to the external os and 2 cm lateral to the cervical canal", "2 cm superior to the cervical flange of the tandem and 2 cm lateral to the central canal", "5 cm lateral to the midline at the level of the pelvic sidewall", "1 cm inferior to the lowest vaginal source and 0.5 cm deep to the vaginal surface", "At the intersection of the ureter and the uterine artery"], "answer": "B", "answer_index": 1, "explanation": "Point A is defined as 2 cm superior to the cervical os (or the flange of the intrauterine tandem) and 2 cm lateral to the central canal (uterine sound). It represents the location where the uterine artery crosses the ureter and is the prescription point for traditional loading patterns to ensure adequate dose to the paracervical triangle. Point B is 3 cm lateral to Point A (pelvic sidewall).", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues that drive a unique best answer: The question specifies the Manchester system for Point A in HDR brachytherapy for cervical cancer, emphasizing traditional reporting. This drives selection based on standard definition: 2 cm superior to the cervical os or tandem flange and 2 cm lateral to the central canal. Option B matches this precisely with 'cervical flange of the tandem' and 'central canal.' Alternatives deviate: A uses 'external os' and 'cervical canal,' which is similar but not the exact traditional phrasing; C describes Point B (pelvic sidewall); D pertains to vaginal mucosa points; E is the anatomical correlate (ureter-uterine artery crossing) but not the geometric definition.\\nMain logical issue(s), if any: None; the stem provides sufficient detail for discriminating a unique best answer without contradictions or underspecification.\\nMain medical accuracy issue(s), if any: None; the keyed answer and rationale align with established radiation oncology standards (e.g., ABS and GEC-ESTRO guidelines), accurately reflecting Point A's definition for dose reporting in cervical brachytherapy.\\nMinimal fix: No fix needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues that drive a unique best answer: The question specifies the Manchester system for Point A in HDR brachytherapy for cervical cancer, emphasizing traditional reporting. This drives selection based on standard definition: 2 cm superior to the cervical os or tandem flange and 2 cm lateral to the central canal. Option B matches this precisely with 'cervical flange of the tandem' and 'central canal.' Alternatives deviate: A uses 'external os' and 'cervical canal,' which is similar but not the exact traditional phrasing; C describes Point B (pelvic sidewall); D pertains to vaginal mucosa points; E is the anatomical correlate (ureter-uterine artery crossing) but not the geometric definition.\nMain logical issue(s), if any: None; the stem provides sufficient detail for discriminating a unique best answer without contradictions or underspecification.\nMain medical accuracy issue(s), if any: None; the keyed answer and rationale align with established radiation oncology standards (e.g., ABS and GEC-ESTRO guidelines), accurately reflecting Point A's definition for dose reporting in cervical brachytherapy.\nMinimal fix: No fix needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-009", "question": "A 62-year-old male with severe COPD is evaluated for Lung Volume Reduction Surgery (LVRS). He has completed pulmonary rehabilitation. Which of the following physiologic parameters is an absolute exclusion criterion for LVRS according to the NETT trial data?", "options": ["FEV1 25% predicted", "DLCO 18% predicted", "Residual Volume 160% predicted", "Upper lobe predominant emphysema on CT", "PaCO2 of 50 mmHg"], "answer": "B", "answer_index": 1, "explanation": "The National Emphysema Treatment Trial (NETT) identified a group of patients at high risk for mortality with LVRS. The high-risk characteristics (exclusion criteria) were FEV1 <= 20% predicted AND either DLCO <= 20% predicted or homogeneous emphysema. A DLCO of 18% is an absolute exclusion due to prohibitive mortality risk. Upper lobe predominance is an *inclusion* or favorable factor. PaCO2 up to 60 mmHg is generally acceptable.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: N (secondary U). Verdict on keyed answer: No defensible answer. Key stem clues: 62-year-old male with severe COPD, completed pulmonary rehabilitation; no specific PFT values (e.g., FEV1) provided, making exclusion criteria assessment incomplete. The question asks for an absolute exclusion criterion per NETT trial, but none of the options qualifies independently. Main logical issue: No option is defensible as an absolute exclusion; NETT high-risk exclusions require combinations (e.g., FEV1 ≤20% predicted AND DLCO ≤20% predicted or homogeneous emphysema), but stem lacks details like FEV1, leading to underspecification where no single parameter excludes outright. Option A (FEV1 25%) is within inclusion range; B (DLCO 18%) not absolute alone; C (RV 160%) meets inclusion; D (upper lobe emphysema) is favorable; E (PaCO2 50) is acceptable (limit ≤60). Main medical accuracy issue: Rationale inaccurately claims DLCO 18% as absolute exclusion, misrepresenting NETT data which requires conjunction with FEV1 ≤20%; this could mislead learners on LVRS criteria. Minimal fix: Add to stem 'FEV1 is 15% predicted' to enable B as the combinatory exclusion criterion, aligning with NETT and supporting the key.\",\n  \"medical_accuracy_score\": 2,\n  \"logical_validity\": false,\n  \"logical_false_reason\": \"N\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N (secondary U). Verdict on keyed answer: No defensible answer. Key stem clues: 62-year-old male with severe COPD, completed pulmonary rehabilitation; no specific PFT values (e.g., FEV1) provided, making exclusion criteria assessment incomplete. The question asks for an absolute exclusion criterion per NETT trial, but none of the options qualifies independently. Main logical issue: No option is defensible as an absolute exclusion; NETT high-risk exclusions require combinations (e.g., FEV1 ≤20% predicted AND DLCO ≤20% predicted or homogeneous emphysema), but stem lacks details like FEV1, leading to underspecification where no single parameter excludes outright. Option A (FEV1 25%) is within inclusion range; B (DLCO 18%) not absolute alone; C (RV 160%) meets inclusion; D (upper lobe emphysema) is favorable; E (PaCO2 50) is acceptable (limit ≤60). Main medical accuracy issue: Rationale inaccurately claims DLCO 18% as absolute exclusion, misrepresenting NETT data which requires conjunction with FEV1 ≤20%; this could mislead learners on LVRS criteria. Minimal fix: Add to stem 'FEV1 is 15% predicted' to enable B as the combinatory exclusion criterion, aligning with NETT and supporting the key.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-010", "question": "A 40-year-old male presents with right calf claudication. Ankle-brachial index is normal at rest but drops to 0.6 after exercise. CT angiography shows a normal appearance of the popliteal artery. However, on physical exam, pedal pulses disappear with active plantar flexion of the foot. Which anatomic variant is most likely responsible?", "options": ["The popliteal artery passes medial to the medial head of the gastrocnemius (Type I)", "The medial head of the gastrocnemius attaches laterally on the femur (Type II)", "An accessory slip of the medial head of the gastrocnemius wraps around the artery (Type III)", "The popliteal artery passes deep to the popliteus muscle (Type IV)", "Cystic degeneration of the popliteal artery adventitia"], "answer": "C", "answer_index": 2, "explanation": "This is Popliteal Artery Entrapment Syndrome (PAES). The loss of pulse with plantar flexion is the key diagnostic maneuver. Type III PAES involves an accessory slip of the medial head of the gastrocnemius muscle that wraps around the popliteal artery, entrapping it. Type I is medial deviation of the artery; Type II is lateral attachment of the muscle. Type III is the muscle slip. (Note: Classification systems vary slightly, but the accessory slip is the distinct feature of Type III in the Rich classification).", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues that drive a unique best answer: 40-year-old male with right calf claudication; normal ABI at rest dropping to 0.6 post-exercise; normal CT angiography of popliteal artery; pedal pulses disappear with active plantar flexion. These point to functional popliteal artery entrapment syndrome (PAES), provoked by plantar flexion maneuver, distinguishing it from fixed lesions like cystic adventitial disease.\\nMain logical issue(s), if any: None; the stem provides sufficient discriminating findings (exertional ABI drop, normal imaging, provocative maneuver) to identify a single best anatomic variant without contradictions or underspecification. Options are well-differentiated by PAES classification types.\\nMain medical accuracy issue(s), if any: None; aligns with standard PAES classification (e.g., Rich system), where Type III involves accessory gastrocnemius slip causing entrapment. The provocative test (pulse loss with plantar flexion) is a classic diagnostic clue, consistent with vascular surgery guidelines and board-level knowledge. Classification variations exist but do not affect the keyed answer's defensibility.\\nMinimal fix: No edit required; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues that drive a unique best answer: 40-year-old male with right calf claudication; normal ABI at rest dropping to 0.6 post-exercise; normal CT angiography of popliteal artery; pedal pulses disappear with active plantar flexion. These point to functional popliteal artery entrapment syndrome (PAES), provoked by plantar flexion maneuver, distinguishing it from fixed lesions like cystic adventitial disease.\nMain logical issue(s), if any: None; the stem provides sufficient discriminating findings (exertional ABI drop, normal imaging, provocative maneuver) to identify a single best anatomic variant without contradictions or underspecification. Options are well-differentiated by PAES classification types.\nMain medical accuracy issue(s), if any: None; aligns with standard PAES classification (e.g., Rich system), where Type III involves accessory gastrocnemius slip causing entrapment. The provocative test (pulse loss with plantar flexion) is a classic diagnostic clue, consistent with vascular surgery guidelines and board-level knowledge. Classification variations exist but do not affect the keyed answer's defensibility.\nMinimal fix: No edit required; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-011", "question": "A 35-year-old female presents with a painless, hard mass on the posterior aspect of the distal thigh. Radiographs reveal a heavily ossified, lobulated mass attached to the posterior femoral cortex with a radiolucent cleft separating the bulk of the tumor from the cortex ('string sign'). Histology shows low-grade spindle cells producing well-formed bone trabeculae. Which molecular finding is characteristic of this lesion?", "options": ["t(X;18) translocation", "MDM2 and CDK4 amplification", "IDH1 mutation", "GNAS mutation", "USP6 rearrangement"], "answer": "B", "answer_index": 1, "explanation": "The imaging (posterior distal femur, parosteal location, string sign) and histology (low-grade bone forming) are classic for Parosteal Osteosarcoma. Unlike conventional high-grade osteosarcoma, Parosteal Osteosarcoma is a low-grade surface lesion characterized by supernumerary ring chromosomes resulting in the amplification of the MDM2 and CDK4 genes. This distinguishes it from osteochondroma or high-grade surface osteosarcoma.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 35-year-old female with painless hard mass on posterior distal thigh; radiographs show heavily ossified lobulated mass attached to posterior femoral cortex with 'string sign' (radiolucent cleft); histology reveals low-grade spindle cells producing well-formed bone trabeculae. These drive a unique best answer by pointing to parosteal osteosarcoma, a low-grade surface bone tumor. Main logical issues: None; the stem provides sufficient discriminating details without contradictions or underspecification, allowing clear selection of one best molecular finding. Main medical accuracy issues: None; aligns with current standards where parosteal osteosarcoma is characterized by MDM2 and CDK4 amplification via supernumerary ring chromosomes, distinguishing it from mimics like osteochondroma or other sarcomas. Minimal fix: None needed.\\n\\nBest-answer defensibility: a) The question asks for the characteristic molecular finding in this bone-forming lesion. b) Key findings: Location (posterior distal femur), painless hard mass, ossified lobulated appearance with string sign, low-grade histology with bone trabeculae. c) Most likely diagnosis: Parosteal osteosarcoma. d) Keyed answer B (MDM2 and CDK4 amplification) fits perfectly as it's a hallmark of this low-grade sarcoma; no major assumptions required. e) A (t(X;18)): Synovial sarcoma translocation, lacks bone formation. C (IDH1): Chondrosarcoma mutation, not matching histology. D (GNAS): Fibrous dysplasia, benign and lacks mass with string sign. E (USP6): Aneurysmal bone cyst, not ossified cortical attachment. Logical validity: V, supports unique best answer matching key. Medical accuracy: Consistent with guidelines; no inaccuracies or outdated info.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 35-year-old female with painless hard mass on posterior distal thigh; radiographs show heavily ossified lobulated mass attached to posterior femoral cortex with 'string sign' (radiolucent cleft); histology reveals low-grade spindle cells producing well-formed bone trabeculae. These drive a unique best answer by pointing to parosteal osteosarcoma, a low-grade surface bone tumor. Main logical issues: None; the stem provides sufficient discriminating details without contradictions or underspecification, allowing clear selection of one best molecular finding. Main medical accuracy issues: None; aligns with current standards where parosteal osteosarcoma is characterized by MDM2 and CDK4 amplification via supernumerary ring chromosomes, distinguishing it from mimics like osteochondroma or other sarcomas. Minimal fix: None needed.\n\nBest-answer defensibility: a) The question asks for the characteristic molecular finding in this bone-forming lesion. b) Key findings: Location (posterior distal femur), painless hard mass, ossified lobulated appearance with string sign, low-grade histology with bone trabeculae. c) Most likely diagnosis: Parosteal osteosarcoma. d) Keyed answer B (MDM2 and CDK4 amplification) fits perfectly as it's a hallmark of this low-grade sarcoma; no major assumptions required. e) A (t(X;18)): Synovial sarcoma translocation, lacks bone formation. C (IDH1): Chondrosarcoma mutation, not matching histology. D (GNAS): Fibrous dysplasia, benign and lacks mass with string sign. E (USP6): Aneurysmal bone cyst, not ossified cortical attachment. Logical validity: V, supports unique best answer matching key. Medical accuracy: Consistent with guidelines; no inaccuracies or outdated info.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-012", "question": "A 55-year-old male presents with persistent, painful, purple-brown nodules on the extensor surfaces of his hands and knees. Histopathology reveals leukocytoclastic vasculitis with concentric fibrosis around blood vessels ('onion-skinning'). Serum protein electrophoresis demonstrates an IgA monoclonal gammopathy. Which of the following is the first-line treatment of choice?", "options": ["Prednisone", "Methotrexate", "Dapsone", "Infliximab", "Cyclophosphamide"], "answer": "C", "answer_index": 2, "explanation": "The diagnosis is Erythema Elevatum Diutinum (EED), a rare chronic leukocytoclastic vasculitis. It is strongly associated with IgA monoclonal gammopathy, HIV, and streptococcal infections. The histology showing LCV with fibrosis is characteristic. Dapsone is the treatment of choice and results in rapid resolution of the lesions. The mechanism is inhibition of neutrophil myeloperoxidase.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Dermatology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. The clinical problem asks for the first-line treatment for a patient with persistent, painful purple-brown nodules on extensor surfaces, histopathology showing leukocytoclastic vasculitis with onion-skin fibrosis, and IgA monoclonal gammopathy. Key stem clues: extensor nodules, leukocytoclastic vasculitis with concentric fibrosis, IgA gammopathy—these strongly imply Erythema Elevatum Diutinum (EED), a rare chronic cutaneous vasculitis. The findings suggest EED as the most likely diagnosis, for which dapsone is the established first-line therapy due to its inhibition of neutrophil myeloperoxidase, leading to rapid lesion resolution. Keyed answer C (Dapsone) fits perfectly, requiring no assumptions beyond standard associations. Alternatives: A (Prednisone) is adjunctive but not first-line for EED; B (Methotrexate) is for refractory cases; D (Infliximab) lacks evidence in EED; E (Cyclophosphamide) is for systemic vasculitides, not this localized form. No main logical issues; stem allows unique best answer without contradictions or underspecification. No medical accuracy issues; aligns with current dermatologic standards (e.g., dapsone as primary treatment per literature on EED associations with IgA gammopathy). Minimal fix: None needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The clinical problem asks for the first-line treatment for a patient with persistent, painful purple-brown nodules on extensor surfaces, histopathology showing leukocytoclastic vasculitis with onion-skin fibrosis, and IgA monoclonal gammopathy. Key stem clues: extensor nodules, leukocytoclastic vasculitis with concentric fibrosis, IgA gammopathy—these strongly imply Erythema Elevatum Diutinum (EED), a rare chronic cutaneous vasculitis. The findings suggest EED as the most likely diagnosis, for which dapsone is the established first-line therapy due to its inhibition of neutrophil myeloperoxidase, leading to rapid lesion resolution. Keyed answer C (Dapsone) fits perfectly, requiring no assumptions beyond standard associations. Alternatives: A (Prednisone) is adjunctive but not first-line for EED; B (Methotrexate) is for refractory cases; D (Infliximab) lacks evidence in EED; E (Cyclophosphamide) is for systemic vasculitides, not this localized form. No main logical issues; stem allows unique best answer without contradictions or underspecification. No medical accuracy issues; aligns with current dermatologic standards (e.g., dapsone as primary treatment per literature on EED associations with IgA gammopathy). Minimal fix: None needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-013", "question": "A 60-year-old male is diagnosed with a high-grade bladder tumor. Cystoscopy reveals a diffuse, edematous, bullous appearance of the bladder mucosa without a discrete mass. Biopsy shows discohesive cells with eccentric nuclei infiltrating the muscularis propria. Immunohistochemistry reveals loss of E-cadherin expression. Which specific mutation is the driver of this variant?", "options": ["FGFR3", "TP53", "CDH1", "RB1", "HRAS"], "answer": "C", "answer_index": 2, "explanation": "This describes Plasmacytoid Urothelial Carcinoma, an aggressive variant of bladder cancer that mimics linitis plastica of the stomach. The hallmark molecular alteration is the loss of function mutation in the CDH1 gene, which encodes E-cadherin. This loss of cell adhesion molecules leads to the discohesive, infiltrative nature of the tumor and a high propensity for peritoneal carcinomatosis.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include diffuse edematous bullous bladder mucosa without discrete mass, biopsy showing discohesive cells with eccentric nuclei infiltrating muscularis propria, and IHC revealing loss of E-cadherin expression—these point to plasmacytoid urothelial carcinoma (PUC), driven by CDH1 mutation causing E-cadherin loss and infiltrative growth. Main logical issue(s): none; the stem provides sufficient discriminating details to identify CDH1 as the unique driver without contradictions or underspecification. Main medical accuracy issue(s): none; aligns with current pathology consensus that CDH1 loss-of-function mutations are hallmark in PUC, an aggressive bladder cancer variant with linitis plastica-like features and peritoneal spread risk. Other options like FGFR3 (low-grade papillary) or TP53/RB1 (general high-grade) lack specificity here. Minimal fix: none needed, as the item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include diffuse edematous bullous bladder mucosa without discrete mass, biopsy showing discohesive cells with eccentric nuclei infiltrating muscularis propria, and IHC revealing loss of E-cadherin expression—these point to plasmacytoid urothelial carcinoma (PUC), driven by CDH1 mutation causing E-cadherin loss and infiltrative growth. Main logical issue(s): none; the stem provides sufficient discriminating details to identify CDH1 as the unique driver without contradictions or underspecification. Main medical accuracy issue(s): none; aligns with current pathology consensus that CDH1 loss-of-function mutations are hallmark in PUC, an aggressive bladder cancer variant with linitis plastica-like features and peritoneal spread risk. Other options like FGFR3 (low-grade papillary) or TP53/RB1 (general high-grade) lack specificity here. Minimal fix: none needed, as the item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-014", "question": "A patient presents with unilateral hearing loss and facial twitching. MRI reveals a non-enhancing, expansile lesion in the petrous apex that is hyperintense on both T1 and T2 weighted images. CT shows smooth bone erosion. What is the most likely diagnosis?", "options": ["Cholesteatoma (Congenital)", "Cholesterol Granuloma", "Chondrosarcoma", "Chordoma", "Petrous Apicitis"], "answer": "B", "answer_index": 1, "explanation": "The key is the MRI signal. Cholesterol Granulomas of the petrous apex are hyperintense on BOTH T1 and T2 sequences due to the presence of hemorrhage and cholesterol crystals (paramagnetic effect of methemoglobin). Congenital cholesteatomas are T1 hypointense (like CSF/tissue) and T2 hyperintense but do not show T1 hyperintensity unless infected/proteinaceous (and usually restrict diffusion). Chondrosarcomas are T1 hypointense/T2 hyperintense with enhancement.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include unilateral hearing loss and facial twitching suggesting cranial nerve involvement, non-enhancing expansile petrous apex lesion hyperintense on both T1 and T2 MRI, and smooth bone erosion on CT, pointing to a cystic or hemorrhagic process like cholesterol granuloma rather than solid tumors or infections. Main logical issue(s): none; the stem provides sufficient discriminating imaging details (T1/T2 hyperintensity, non-enhancement, smooth erosion) to identify a unique best without contradictions or underspecification. Main medical accuracy issue(s): none; aligns with standard radiology knowledge where cholesterol granulomas exhibit T1/T2 hyperintensity due to methemoglobin and cholesterol, distinguishing from cholesteatoma (T1 hypointense unless complicated), chondrosarcoma/chordoma (enhancing, T1 hypo/iso), and petrous apicitis (enhancing inflammation). The item's logic is consistent with current guidelines on petrous apex lesions, emphasizing MRI signal for differentiation. Minimal fix: none needed, as the item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include unilateral hearing loss and facial twitching suggesting cranial nerve involvement, non-enhancing expansile petrous apex lesion hyperintense on both T1 and T2 MRI, and smooth bone erosion on CT, pointing to a cystic or hemorrhagic process like cholesterol granuloma rather than solid tumors or infections. Main logical issue(s): none; the stem provides sufficient discriminating imaging details (T1/T2 hyperintensity, non-enhancement, smooth erosion) to identify a unique best without contradictions or underspecification. Main medical accuracy issue(s): none; aligns with standard radiology knowledge where cholesterol granulomas exhibit T1/T2 hyperintensity due to methemoglobin and cholesterol, distinguishing from cholesteatoma (T1 hypointense unless complicated), chondrosarcoma/chordoma (enhancing, T1 hypo/iso), and petrous apicitis (enhancing inflammation). The item's logic is consistent with current guidelines on petrous apex lesions, emphasizing MRI signal for differentiation. Minimal fix: none needed, as the item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-015", "question": "A 50-year-old patient in the ICU for 3 weeks with sepsis and multi-organ failure is noted to have flaccid quadriparesis. Sensory nerve conduction studies are normal. Motor nerve conduction studies show reduced CMAP amplitudes with increased duration, but no conduction block. Needle EMG reveals abundant spontaneous activity and short-duration, low-amplitude motor unit potentials. Muscle biopsy shows selective loss of myosin filaments. What is the diagnosis?", "options": ["Critical Illness Polyneuropathy (CIP)", "Critical Illness Myopathy (CIM)", "Guillain-Barre Syndrome", "Motor Neuron Disease", "Botulism"], "answer": "B", "answer_index": 1, "explanation": "Differentiation between CIP and CIM in the ICU is difficult but crucial. The preservation of sensory nerve action potentials (SNAPs) strongly favors Myopathy (CIM) over Polyneuropathy (CIP), as CIP is a sensorimotor axonal neuropathy. The specific biopsy finding of 'selective loss of myosin filaments' (myosinolysis) is pathognomonic for Critical Illness Myopathy (specifically the acute quadriplegic myopathy type).", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include flaccid quadriparesis in a septic ICU patient, normal sensory nerve conduction studies, reduced CMAP amplitudes with increased duration but no conduction block on motor studies, abundant spontaneous EMG activity with short-duration low-amplitude motor unit potentials, and muscle biopsy showing selective loss of myosin filaments. These findings—particularly preserved sensory potentials and pathognomonic myosinolysis—point uniquely to Critical Illness Myopathy (CIM) over neuropathy or other differentials. No main logical issues; the vignette provides sufficient discriminating details without contradictions or underspecification, allowing clear selection of one best option. No main medical accuracy issues; the item's pathophysiology, electrodiagnostic correlations, and biopsy findings align with current mainstream standards for CIM diagnosis, consistent with guidelines from critical care and neuromuscular medicine (e.g., selective thick filament loss in CIM subtypes). The rationale correctly emphasizes sensory preservation favoring myopathy. Minimal fix: No edit required, as the item is already unambiguous and accurate; optionally, add 'thick filament' to biopsy description for added precision without altering meaning.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include flaccid quadriparesis in a septic ICU patient, normal sensory nerve conduction studies, reduced CMAP amplitudes with increased duration but no conduction block on motor studies, abundant spontaneous EMG activity with short-duration low-amplitude motor unit potentials, and muscle biopsy showing selective loss of myosin filaments. These findings—particularly preserved sensory potentials and pathognomonic myosinolysis—point uniquely to Critical Illness Myopathy (CIM) over neuropathy or other differentials. No main logical issues; the vignette provides sufficient discriminating details without contradictions or underspecification, allowing clear selection of one best option. No main medical accuracy issues; the item's pathophysiology, electrodiagnostic correlations, and biopsy findings align with current mainstream standards for CIM diagnosis, consistent with guidelines from critical care and neuromuscular medicine (e.g., selective thick filament loss in CIM subtypes). The rationale correctly emphasizes sensory preservation favoring myopathy. Minimal fix: No edit required, as the item is already unambiguous and accurate; optionally, add 'thick filament' to biopsy description for added precision without altering meaning.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-016", "question": "A 22-year-old male presents with a scaphoid waist nonunion established for 8 months. CT scan demonstrates a 'humpback' deformity with a dorsal intercalated segment instability (DISI) pattern and intrascaphoid angle of 60 degrees. There is no avascular necrosis. Which graft technique is indicated to correct the deformity and mechanics?", "options": ["Russe inlay bone graft", "Vascularized bone graft from the distal radius (1,2 ICSRA)", "Matti-Russe procedure", "Volar wedge interposition graft (Fisk-Fernandez)", "Proximal row carpectomy"], "answer": "D", "answer_index": 3, "explanation": "The scaphoid humpback deformity (flexion of the distal pole relative to the proximal pole) results in carpal collapse (DISI). A Russe inlay graft (or Matti-Russe) is packed into the void but does not structurally correct the flexion deformity/length. To restore scaphoid length and correct the humpback (and thus the DISI), a structural corticocancellous wedge graft is required, placed via a volar approach (Fisk-Fernandez technique) to prop the scaphoid open into extension.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues that drive a unique best answer: 22-year-old with 8-month scaphoid waist nonunion, CT-confirmed humpback deformity, DISI pattern, intrascaphoid angle 60 degrees, and absence of avascular necrosis. These indicate need for deformity correction to restore scaphoid length and carpal mechanics, pointing to a structural graft technique.\\nMain logical issue(s), if any: None; stem provides sufficient details for discrimination without contradictions or underspecification, allowing a single best answer (D) while eliminating others.\\nMain medical accuracy issue(s), if any: None; aligns with orthopedic consensus (e.g., AAOS/ASSH guidelines) that Fisk-Fernandez volar wedge graft is indicated for humpback nonunions without AVN to correct flexion deformity and DISI, whereas Russe/Matti-Russe (A/C) suit non-deformed nonunions, vascularized grafts (B) address AVN, and PRC (E) is salvage for arthritis.\\nMinimal fix: No edit needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues that drive a unique best answer: 22-year-old with 8-month scaphoid waist nonunion, CT-confirmed humpback deformity, DISI pattern, intrascaphoid angle 60 degrees, and absence of avascular necrosis. These indicate need for deformity correction to restore scaphoid length and carpal mechanics, pointing to a structural graft technique.\nMain logical issue(s), if any: None; stem provides sufficient details for discrimination without contradictions or underspecification, allowing a single best answer (D) while eliminating others.\nMain medical accuracy issue(s), if any: None; aligns with orthopedic consensus (e.g., AAOS/ASSH guidelines) that Fisk-Fernandez volar wedge graft is indicated for humpback nonunions without AVN to correct flexion deformity and DISI, whereas Russe/Matti-Russe (A/C) suit non-deformed nonunions, vascularized grafts (B) address AVN, and PRC (E) is salvage for arthritis.\nMinimal fix: No edit needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-017", "question": "A 12-year-old male with a history of drug-resistant complex partial seizures undergoes resection of a temporal lobe lesion. MRI showed a cortically based, wedge-shaped, 'bubbly' cystic-solid lesion without edema. Histopathology reveals columns of neurons floating in a mucinous matrix with specific glioneuronal elements. What is the diagnosis?", "options": ["Ganglioglioma", "Dysembryoplastic Neuroepithelial Tumor (DNET)", "Pleomorphic Xanthoastrocytoma (PXA)", "Pilocytic Astrocytoma", "Oligodendroglioma"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation (chronic epilepsy in a child/young adult), imaging ('bubbly' intracortical lesion, no edema), and histology (specific glioneuronal element with 'floating neurons' in a mucinous/myxoid background) are pathognomonic for Dysembryoplastic Neuroepithelial Tumor (DNET). Gangliogliomas have binucleate neurons and eosinophilic granular bodies but lack the specific floating neuron/mucinous column architecture.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 12-year-old with drug-resistant complex partial seizures; temporal lobe lesion; MRI showing cortically based, wedge-shaped, 'bubbly' cystic-solid lesion without edema; histopathology with columns of neurons floating in a mucinous matrix and specific glioneuronal elements. These features—pediatric epilepsy, bubbly cortical lesion, and floating neurons in mucin—are pathognomonic for DNET, making B the unique best. Main logical issue(s): None; stem provides sufficient discriminating details without contradictions or underspecification, allowing clear differentiation from alternatives. Main medical accuracy issue(s): None; aligns with standard neuropathology (e.g., WHO classification), where DNET is a benign glioneuronal tumor associated with intractable epilepsy in children/young adults, featuring specific histology of oligodendroglia-like cells, floating neurons, and mucinous matrix; imaging matches typical non-enhancing, cystic appearance. Alternatives are appropriately distractors: Ganglioglioma lacks mucinous columns; PXA is more pleomorphic and superficial but not bubbly; Pilocytic astrocytoma has Rosenthal fibers without glioneuronal elements; Oligodendroglioma shows infiltrative growth and lacks neurons. Minimal fix: None needed; item is already unambiguous and accurate.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 12-year-old with drug-resistant complex partial seizures; temporal lobe lesion; MRI showing cortically based, wedge-shaped, 'bubbly' cystic-solid lesion without edema; histopathology with columns of neurons floating in a mucinous matrix and specific glioneuronal elements. These features—pediatric epilepsy, bubbly cortical lesion, and floating neurons in mucin—are pathognomonic for DNET, making B the unique best. Main logical issue(s): None; stem provides sufficient discriminating details without contradictions or underspecification, allowing clear differentiation from alternatives. Main medical accuracy issue(s): None; aligns with standard neuropathology (e.g., WHO classification), where DNET is a benign glioneuronal tumor associated with intractable epilepsy in children/young adults, featuring specific histology of oligodendroglia-like cells, floating neurons, and mucinous matrix; imaging matches typical non-enhancing, cystic appearance. Alternatives are appropriately distractors: Ganglioglioma lacks mucinous columns; PXA is more pleomorphic and superficial but not bubbly; Pilocytic astrocytoma has Rosenthal fibers without glioneuronal elements; Oligodendroglioma shows infiltrative growth and lacks neurons. Minimal fix: None needed; item is already unambiguous and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-018", "question": "A patient with small cell lung cancer presents with Superior Vena Cava (SVC) syndrome. He is hemodynamically stable but has significant facial edema and dyspnea. He is scheduled for emergent radiation therapy. What is the typical fractionation scheme recommended to minimize the risk of initial symptom worsening?", "options": ["10 Gy in 1 fraction", "2 Gy per fraction daily", "High dose per fraction (3-4 Gy) for the first few treatments", "Standard fractionation (1.8 Gy) with concurrent chemotherapy", "Twice daily hyperfractionation"], "answer": "C", "answer_index": 2, "explanation": "This is a classic 'trick' or counter-intuitive principle in palliative RadOnc. While one might fear edema with high doses, the standard emergent regimen for SVC obstruction (or spinal cord compression) often utilizes *high* initial doses (e.g., 3 Gy x 2-3 or 4 Gy x 1-2) to achieve rapid tumor cell kill and debulking, followed by standard fractionation. Low doses (1.8-2 Gy) may be too slow to relieve obstruction. Steroids are given concurrently to manage radiation-induced edema.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include small cell lung cancer (radiosensitive histology implying rapid response to RT), SVC syndrome with facial edema and dyspnea (urgent need for debulking), hemodynamic stability (allows RT without immediate intervention), and emergent radiation therapy scheduling (focus on fractionation to minimize initial worsening). These clues support high initial doses for quick tumor kill, reducing obstruction risk before edema peaks. Main logical issue(s): None; the stem provides sufficient details for discriminating C as uniquely best, with alternatives either too aggressive (A risks severe edema), too slow (B, D for emergent relief), or not standard (E). Main medical accuracy issue(s): None; aligns with palliative radiation oncology standards for SVC syndrome in SCLC, where initial 3-4 Gy fractions (e.g., x2-3) followed by standard dosing rapidly palliates while steroids mitigate edema—consistent with NCCN and ASTRO guidelines, avoiding outdated low-dose only approaches. Minimal fix: None required; item is unambiguous and accurate as written.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include small cell lung cancer (radiosensitive histology implying rapid response to RT), SVC syndrome with facial edema and dyspnea (urgent need for debulking), hemodynamic stability (allows RT without immediate intervention), and emergent radiation therapy scheduling (focus on fractionation to minimize initial worsening). These clues support high initial doses for quick tumor kill, reducing obstruction risk before edema peaks. Main logical issue(s): None; the stem provides sufficient details for discriminating C as uniquely best, with alternatives either too aggressive (A risks severe edema), too slow (B, D for emergent relief), or not standard (E). Main medical accuracy issue(s): None; aligns with palliative radiation oncology standards for SVC syndrome in SCLC, where initial 3-4 Gy fractions (e.g., x2-3) followed by standard dosing rapidly palliates while steroids mitigate edema—consistent with NCCN and ASTRO guidelines, avoiding outdated low-dose only approaches. Minimal fix: None required; item is unambiguous and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-019", "question": "A 55-year-old male presents with an anterior mediastinal mass. Resection reveals a high-grade malignancy. Immunohistochemistry shows the tumor cells are positive for CD5 and CD117 (c-KIT), but negative for TdT and CD1a. What is the diagnosis?", "options": ["Thymoma (Type B3)", "Thymic Carcinoma", "T-cell Lymphoblastic Lymphoma", "Seminoma", "Mediastinal Large B-cell Lymphoma"], "answer": "B", "answer_index": 1, "explanation": "Differentiation of Thymic epithelial tumors is complex. Thymomas (A, AB, B1, B2, B3) are generally CD5 negative and CD117 negative (or weak). Thymic Carcinoma (Type C) is characteristically CD5 positive (an aberrant marker for epithelial cells) and CD117 (c-KIT) positive. T-cell lymphoma would be TdT positive. Seminoma is CD117 positive but CD5 negative and PLAP/OCT4 positive.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 55-year-old male with anterior mediastinal mass, high-grade malignancy on resection, IHC positive for CD5 and CD117 (c-KIT), negative for TdT and CD1a. These markers specifically point to thymic carcinoma, as it aberrantly expresses CD5 in epithelial cells and is CD117+, while ruling out T-cell lymphoblastic lymphoma (TdT+ expected) and immature T-cell markers (CD1a-). No main logical issues; the stem provides sufficient discriminating IHC details to identify a single best diagnosis without contradictions or underspecification. No main medical accuracy issues; aligns with standard pathology (e.g., WHO classification of thymic tumors), where thymic carcinoma is CD5+/CD117+, distinguishing it from thymoma (CD5-/CD117- or weak) and other mediastinal tumors like seminoma (CD117+ but CD5-, PLAP+). Item is clinically realistic and board-relevant. Minimal fix: None needed, as the item is already unambiguous and accurate; optionally, add 'PLAP negative' to stem to further exclude seminoma explicitly, though not required.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer: 55-year-old male with anterior mediastinal mass, high-grade malignancy on resection, IHC positive for CD5 and CD117 (c-KIT), negative for TdT and CD1a. These markers specifically point to thymic carcinoma, as it aberrantly expresses CD5 in epithelial cells and is CD117+, while ruling out T-cell lymphoblastic lymphoma (TdT+ expected) and immature T-cell markers (CD1a-). No main logical issues; the stem provides sufficient discriminating IHC details to identify a single best diagnosis without contradictions or underspecification. No main medical accuracy issues; aligns with standard pathology (e.g., WHO classification of thymic tumors), where thymic carcinoma is CD5+/CD117+, distinguishing it from thymoma (CD5-/CD117- or weak) and other mediastinal tumors like seminoma (CD117+ but CD5-, PLAP+). Item is clinically realistic and board-relevant. Minimal fix: None needed, as the item is already unambiguous and accurate; optionally, add 'PLAP negative' to stem to further exclude seminoma explicitly, though not required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed129", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed129-020", "question": "A 30-year-old female presents with a painless, pulsatile neck mass. Imaging reveals a vascular tumor at the carotid bifurcation that splays the internal and external carotid arteries ('Lyre sign'). The tumor encases the internal carotid artery fully (360 degrees) but does not narrow the lumen. According to the Shamblin classification, what is the class of this tumor?", "options": ["Shamblin I", "Shamblin II", "Shamblin III", "Shamblin IV", "Fisch Type A"], "answer": "C", "answer_index": 2, "explanation": "The Shamblin classification predicts the difficulty of surgical resection for Carotid Body Tumors (Paragangliomas). Class I: Minimal attachment, easily resectable. Class II: Partial encirclement, adherent but resectable. Class III: Intimate adherence and complete encirclement of the carotid vessels, often requiring vessel resection and reconstruction. The key here is 'encases the internal carotid artery fully', which defines Shamblin III.", "generator_model": "gemini-3-pro-preview", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "grok-4-0709", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include painless pulsatile neck mass, vascular tumor at carotid bifurcation splaying internal and external carotid arteries ('Lyre sign'), and full 360-degree encasement of the internal carotid artery without lumen narrowing. These findings classically indicate a carotid body tumor (paraganglioma) with advanced vessel involvement, pointing to Shamblin III classification. Main logical issue(s): None; the stem is internally consistent, supports a single best answer, and discriminates options effectively without requiring unstated assumptions. Main medical accuracy issue(s): None; the item's logic aligns with established Shamblin classification for carotid body tumors, where Class III involves complete vessel encirclement often necessitating resection/reconstruction, consistent with current surgical and radiological standards (e.g., no Shamblin IV exists, and Fisch classification applies to temporal bone paragangliomas). The vignette is clinically realistic and board-relevant. Minimal fix: None required, as the item is unambiguous and accurate; optionally, remove option D (Shamblin IV) to eliminate a non-existent distractor, though it doesn't undermine validity.\",\n  \"medical_accuracy_score\": 5,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues that drive a unique best answer include painless pulsatile neck mass, vascular tumor at carotid bifurcation splaying internal and external carotid arteries ('Lyre sign'), and full 360-degree encasement of the internal carotid artery without lumen narrowing. These findings classically indicate a carotid body tumor (paraganglioma) with advanced vessel involvement, pointing to Shamblin III classification. Main logical issue(s): None; the stem is internally consistent, supports a single best answer, and discriminates options effectively without requiring unstated assumptions. Main medical accuracy issue(s): None; the item's logic aligns with established Shamblin classification for carotid body tumors, where Class III involves complete vessel encirclement often necessitating resection/reconstruction, consistent with current surgical and radiological standards (e.g., no Shamblin IV exists, and Fisch classification applies to temporal bone paragangliomas). The vignette is clinically realistic and board-relevant. Minimal fix: None required, as the item is unambiguous and accurate; optionally, remove option D (Shamblin IV) to eliminate a non-existent distractor, though it doesn't undermine validity.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]